Anuj Khandelwal is the CEO and Co-Founder of Empo Health, a San Bruno, CA-based medical device company developing in-home monitoring systems to prevent diabetic foot amputations. With a BS in Mechanical Engineering from MIT and MS in Mechanical Engineering (Medical Devices) from Stanford, Khandelwal founded Empo Health in 2020 alongside co-founder Eric Dahlseng. The company's flagship product — Empo Footprint, an FDA-listed in-home imaging scale — lets diabetic patients monitor foot health from home, transmitting images to care teams for early intervention. In June 2025, Empo Health raised a $7 million round led by Story Ventures to commercialize its remote diabetic foot ulcer management system.
Don Vaughn, Ph.D. is the Co-Founder and CEO of Ampa Health, a Palo Alto-based neurotechnology company building FDA-cleared portable TMS (transcranial magnetic stimulation) devices that compress 36 days of depression treatment into a single day. A Stanford-educated physicist turned UCLA neuroscientist, Vaughn has built a career at the intersection of brain science, machine learning, and accessibility - detoured, notably, through a DJ career that landed him a #28 iTunes Dance chart hit featuring Nick Lachey. His TEDx talk on neurohacking has surpassed one million views. Ampa raised an oversubscribed $8.5M pre-A round in October 2025, achieved FDA clearance for its Ampa One device in February 2025, and is targeting 5,000 patient remissions by end of 2026 - with a long-term audacious goal of a billion remissions in ten years.